Table 2.
Pharmacokinetic measures of interest by study treatment in the 20 participants completing a cross-over study of three formulations containing 600 mg of rifampicin
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.